Target
MAP kinase-interacting serine/threonine-protein kinase 2
Ligand
BDBM50455540
Substrate
n/a
Meas. Tech.
ChEMBL_1754737 (CHEMBL4189497)
IC50
193±n/a nM
Citation
 Yang, HChennamaneni, LRHo, MWTAng, SHTan, ESWJeyaraj, DAYeap, YSLiu, BOng, EHJoy, JKWee, JLKKwek, PRetna, PDinie, NNguyen, TTHTai, SJManoharan, VPendharkar, VLow, CBChew, YSVuddagiri, SSangthongpitag, KChoong, MLLee, MAKannan, SVerma, CSPoulsen, ALim, SChuah, COng, TSHill, JMatter, ANacro, K Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia. J Med Chem 61:4348-4369 (2018) [PubMed]  Article 
Target
Name:
MAP kinase-interacting serine/threonine-protein kinase 2
Synonyms:
GPRK7 | MAP kinase signal-integrating kinase 2 | MAP kinase-interacting serine/threonine-protein kinase 2 (MKNK2) | MAP kinase-interacting serine/threonine-protein kinase 2 (MnK2) | MAP-kinase interacting kinase 2 (MNK2) | MKNK2 | MKNK2_HUMAN | MNK2
Type:
Protein
Mol. Mass.:
51870.79
Organism:
Homo sapiens (Human)
Description:
Q9HBH9
Residue:
465
Sequence:
MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA
  
Inhibitor
Name:
BDBM50455540
Synonyms:
CHEMBL4212480
Type:
Small organic molecule
Emp. Form.:
C19H14N4O2
Mol. Mass.:
330.3401
SMILES:
NC(=O)c1ccc(cc1)-c1cn2c(cnc2cn1)-c1ccc(O)cc1
Structure:
Search PDB for entries with ligand similarity: